Pharmacy
Insurers are picking up more of the cost of prescription pain drugs, according to a study linking that trend with the rise in opioid-related deaths.
Transparency in how drug companies set pricing is needed to reform the pharmaceuticals industry, The Campaign for Sustainable Drug Pricing claims in a new series of proposals aimed at making the prescription drug marketplace more open and competitive.
The absence of more stores like CVS that are easily accessible to people in impoverished, predominantly black neighborhoods underscores Baltimore's other persistent inequities.
Blood testing startup Theranos is under investigation by the U.S. Securities and Exchange Commission and the U.S. Attorney's Office for the Northern District of California.
Third-party nonprofits promising scientific and transparent drug value assessments are gaining ground in healthcare, even as many drug manufacturers are challenging their methodologies, according to new research by the Health Research Institute.
Pharmaceutical company Warner Chilcott was sentenced Friday in U.S. District Court in Boston to pay $125 million to resolve criminal and civil liability stemming from the illegal promotion of various drugs including Actonel, Asacol, Atelvia, Doryx, Enablex, Estrace, Loestrin and various formulations of these drugs, the U.S. Attorney's Office announced Friday.
Customers at their corner CVS Health MinuteClinics in Ohio now can access clinicians at the prestigious Cleveland Clinic via online and mobile telehealth technology from vendor American Well.
In the battle against America's surging opioid drug addiction, 49 states, the District of Columbia and even Guam have all implemented some kind of PMDP. Missouri is the only state that hasn't. A protracted political battle has kept the state from passing a law to establish one. That leaves pharmacists like Logan with few options.
Rite Aid earned nearly $166 million and opened 23 health clinics in 2015, the company announced in what may be its last full-year earnings report before its scheduled takeover by Walgreens.
Facing new measures by the U.S. Treasury to thwart tax-evading deals, drugmaker Pfizer has officially jettisoned its $160 billion agreement to buy Allergan, according to published reports.